Strona główna・Stock List・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Closed

SectorHealthcare

575.5 -0.21

Buy Sell

Overview

Share price change

24h

Current

Min

573.61

Max

577.21

Key metrics
By Trading Economics
Income	85M 1.7B
Sales	989M 12B
P/E Sector Avg	30.575 64.641
EPS	6.03
Dividend yield	0.15
Profit margin	14.516
Employees	125,000
EBITDA	262M 2.6B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+6.98% upside

Dividends
By Acuity
Dividend yield Sector Avg	0.15% 2.31%
Next Earnings	21 paź 2026
Next Dividend date	15 paź 2026
Next Ex Dividend date	15 wrz 2026

Market Stats
By TradingEconomics
Market Cap	17B 213B
Previous open	575.71
Previous close	575.5

News Sentiment

By Acuity

33%

67%

90 / 340 Ranking in Healthcare

Thermo Fisher Scientific Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

1 sie 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31 lip 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 lip 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 lip 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 lip 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 lip 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 lip 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 lip 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 lip 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 lip 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 lip 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Peer Comparison

Price change

Thermo Fisher Scientific Inc Forecast

Price Target

By TipRanks

6.98% upside

12 Months Forecast

Average 614.41 USD 6.98%

High 690 USD

Low 520 USD

Based on 19 Wall Street analysts offering 12 month price targets forThermo Fisher Scientific Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

19 ratings

Buy

Hold

Sell

Based on 19 analysts giving stock ratings to Thermo Fisher Scientific Inc - Dist in the past 3 months.

Sentiment

By Acuity

90 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar